Follow
Sandrine Silvente-Poirot
Sandrine Silvente-Poirot
Directeur de recherche CNRS
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
106212021
Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies
M Record, K Carayon, M Poirot, S Silvente-Poirot
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2014
8892014
Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins [S]
C Subra, D Grand, K Laulagnier, A Stella, G Lambeau, M Paillasse, ...
Journal of lipid research 51 (8), 2105-2120, 2010
7062010
Exosomes as intercellular signalosomes and pharmacological effectors
M Record, C Subra, S Silvente-Poirot, M Poirot
Biochemical pharmacology 81 (10), 1171-1182, 2011
6002011
Extracellular vesicles: lipids as key components of their biogenesis and functions
M Record, S Silvente-Poirot, M Poirot, MJO Wakelam
Journal of Lipid Research 59 (8), 1316-1324, 2018
2602018
Cholesterol and cancer, in the balance
S Silvente-Poirot, M Poirot
Science 343 (6178), 1445-1446, 2014
2302014
The peripheral cholecystokinin receptors
S SILVENTE‐POIROT, M DUFRESNE, N VAYSSE, D FOURMY
European journal of biochemistry 215 (3), 513-529, 1993
1441993
Identification and pharmacological characterization of cholesterol-5, 6-epoxide hydrolase as a target for tamoxifen and AEBS ligands
P de Medina, MR Paillasse, G Segala, M Poirot, S Silvente-Poirot
Proceedings of the National Academy of Sciences 107 (30), 13520-13525, 2010
1292010
Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties
P De Médina, MR Paillasse, G Segala, M Voisin, L Mhamdi, F Dalenc, ...
Nature communications 4 (1), 1840, 2013
1142013
Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation
P de Medina, S Silvente-Poirot, M Poirot
Autophagy 5 (7), 1066-1067, 2009
1092009
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor
M Voisin, P De Medina, A Mallinger, F Dalenc, E Huc-Claustre, ...
Proceedings of the National Academy of Sciences 114 (44), E9346-E9355, 2017
1082017
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
G Segala, M David, P De Médina, MC Poirot, N Serhan, F Vergez, ...
Nature communications 8 (1), 1903, 2017
972017
Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells
P De Médina, BL Payre, J Bernad, I Bosser, B Pipy, S Silvente-Poirot, ...
Journal of Pharmacology and Experimental Therapeutics 308 (3), 1165-1173, 2004
952004
Cholesterol metabolism and cancer: the good, the bad and the ugly.
S Silvente-Poirot, M Poirot
Current opinion in pharmacology 12 (6), 673-6, 2012
942012
Molecular characterization of the microsomal tamoxifen binding site
B Kedjouar, P de Médina, M Oulad-Abdelghani, B Payré, ...
Journal of Biological Chemistry 279 (32), 34048-34061, 2004
942004
Emerging concepts on the role of exosomes in lipid metabolic diseases
M Record, M Poirot, S Silvente-Poirot
Biochimie 96, 67-74, 2014
862014
Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism
P De Médina, B Payré, N Boubekeur, J Bertrand-Michel, F Tercé, ...
Cell Death & Differentiation 16 (10), 1372-1384, 2009
862009
Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin
V Gigoux, C Escrieut, JA Fehrentz, S Poirot, B Maigret, L Moroder, D Gully, ...
Journal of Biological Chemistry 274 (29), 20457-20464, 1999
861999
Cholesterol epoxide hydrolase and cancer
S Silvente-Poirot, M Poirot
Current opinion in pharmacology 12 (6), 696-703, 2012
852012
Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state
V Gigoux, C Escrieut, S Silvente-Poirot, B Maigret, L Gouilleux, ...
Journal of biological chemistry 273 (23), 14380-14386, 1998
841998
The system can't perform the operation now. Try again later.
Articles 1–20